ARTICLE
30 March 2023

Wyoming To Ban Abortion Medication

SG
Shipman & Goodwin LLP

Contributor

Shipman & Goodwin’s value lies in our commitment -- to our clients, to the profession and to the community. We have one goal: to help our clients achieve their goals. How we accomplish it is simple: we devote our considerable experience and depth of knowledge to understand each client’s unique needs, business and industry, and then we develop solutions to meet those needs. Clients turn to us when they need a trusted advisor. With our invaluable awareness of each client’s challenges, we can counsel them at every step -- to keep their operations running smoothly, help them navigate complex business transactions, position them for future growth, or resolve business disputes. The success of our clients is of primary importance to us and our attorneys invest meaningful time getting to know the client's business and are skilled in the practice areas and industry sectors critical to that success. With more than 175 attorneys in offices throughout Connecticut, New York and in Washington, DC, we serve the needs of
Abortion medications, such as mifepristone, have been considered by many to be the equivalent of a safe harbor for women seeking abortion in states where abortion is either banned or restricted.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Abortion medications, such as mifepristone, have been considered by many to be the equivalent of a safe harbor for women seeking abortion in states where abortion is either banned or restricted. On Friday, Wyoming became the first state to ban chemical abortions when Governor Gordon of Wyoming signed into law a ban on the sale, use, or prescribing of chemical abortions.

The law goes into effect July 1, 2023, and violation is a misdemeanor punishable by imprisonment for not more than six (6) months, a fine of up to $9,000, or both. Interestingly, the law does not expressly name mifepristone, which is viewed as a defensive move to prevent drug manufacturers from coming up with a new or different named comparable medication. Notably, there are exceptions relating to the treatment of a "natural miscarriage," or treatment that is, "necessary to preserve the woman from an imminent peril that substantially endangers her life or health...." According to the Pew Research Center, chemical abortions represent a majority of pregnancy terminations in the United States.

Additionally, on March 19, 2023, another more broadly drafted bill banning abortion in Wyoming became law. The intention of this law was to proactively defend any further constitutional challenges by claiming that abortion is not health care. An earlier statutory abortion ban was enjoined by a federal district court because it was believed to violate the state constitution. As a result, at this time, abortion is banned in Wyoming.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

ARTICLE
30 March 2023

Wyoming To Ban Abortion Medication

United States Food, Drugs, Healthcare, Life Sciences

Contributor

Shipman & Goodwin’s value lies in our commitment -- to our clients, to the profession and to the community. We have one goal: to help our clients achieve their goals. How we accomplish it is simple: we devote our considerable experience and depth of knowledge to understand each client’s unique needs, business and industry, and then we develop solutions to meet those needs. Clients turn to us when they need a trusted advisor. With our invaluable awareness of each client’s challenges, we can counsel them at every step -- to keep their operations running smoothly, help them navigate complex business transactions, position them for future growth, or resolve business disputes. The success of our clients is of primary importance to us and our attorneys invest meaningful time getting to know the client's business and are skilled in the practice areas and industry sectors critical to that success. With more than 175 attorneys in offices throughout Connecticut, New York and in Washington, DC, we serve the needs of
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More